In breast cancer, both CD8+ and Foxp3+ TILs increased after NAC, but CD8+ lymphocytes increased more dramatically resulting an elevated CD8+/FOXP3+ ratio [14]. This evidence concerns the gene FOXP3 and breast cancer.